Myocardial Dysfunction in Early Diabetes Patients with Microalbuminuria: A 2-Dimensional Speckle Tracking Strain Study

Cell Biochemistry and Biophysics

Volumn 70, Issue 1, 2014, Pages 573-578

  Guo, Ran ^a   Wang, Ke ^a   Song, Wei ^a   Cong, Tao ^a   Shang, Zhi Juan ^a   Sun, Ying Hui ^a   Jiang, Yi Nong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

2 Dimensional speckle tracking strain; Diabetes; Hypertension; Microalbuminuria

Indexed keywords

CREATININE;

ADULT; ALBUMINURIA; COMPLICATION; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; URINE;

ADULT; ALBUMINURIA; CREATININE; DIABETES COMPLICATIONS; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED;

EID: 84906215022     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9958-8     Document Type: Article

References (46)

1. Galderisi, M. (2006). Diastolic dysfunction and diabetic cardiomyopathy: Evaluation by Doppler echocardiography. Journal of the American College of Cardiology, 48, 1548-1551.
2. Poirier, P., Bogaty, P., Garneau, C., Marois, L., & Dumesnil, J. G. (2001). Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care, 24, 5-10.
3. Zhao, C. T., Wang, M., Siu, C. W., Hou, Y. L., Wang, T., Tse, H. F., et al. (2012). Myocardial dysfunction in patients with type 2 diabetes mellitus: Role of endothelial progenitor cells and oxidative stress. Cardiovascular Diabetology, 5, 147.
4. Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004). Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocrine Reviews, 25, 543-567.
5. Gerstein, H. C., Mann, J. F., Yi, Q., Zinman, B., Dinneen, S. F., Hoogwerf, B., et al. (2001). Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA, 286, 421-426.
6. Bigazzi, R., Bianchi, S., Baldari, D., & Campese, V. M. (1998). Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. Journal of Hypertension, 16, 1325-1333.
7. Futrakul, N., Sridama, V., & Futrakul, P. (2009). Microalbuminuria-A biomarker of renal microvascular disease. Renal Failure, 31, 140-143.
8. Klausen, K. P., Scharling, H., & Jensen, J. S. (2006). Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. Journal of Internal Medicine, 260, 231-237.
9. Agha, A., Amer, W., Anwar, E., & Bashir, K. (2009). Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial. Saudi Journal of Kidney Diseases and Transplantation, 20, 429-435.
10. Keane, W. F., & Eknoyan, G. (1999). Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. American Journal of Kidney Diseases, 33, 1004-1010.
11. Derhaschnig, U., Kittler, H., Woisetschlager, C., Bur, A., Herkner, H., & Hirschl, M. M. (2002). Microalbumin measurement alone or calculation of the albumin/creatinine ratio for the screening of hypertension patients? Nephrology, Dialysis, Transplantation, 17, 81-85.
12. de Zeeuw, D., Parving, H. H., & Henning, R. H. (2006). Microalbuminuria as an early marker for cardiovascular disease. Journal of the American Society of Nephrology, 17, 2100-2105.
13. Verdecchia, P., Angeli, F., Cavallini, C., Mazzotta, G., Repaci, S., Pede, S., et al. (2009). The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. Journal of Hypertension, 27, 1697-1704.
14. Nunes, S., Soares, E., Fernandes, J., Viana, S., Carvalho, E., Pereira, F. C., et al. (2013). Early cardiac changes in a rat model of prediabetes: Brain natriuretic peptide overexpression seems to be the best marker. Cardiovascular Diabetology, 12, 44.
15. Mewton, N., Opdahl, A., Choi, E. Y., Almeida, A. L., Kawel, N., Wu, C. O., et al. (2013). Left ventricular global function index by magnetic resonance imaging-A novel marker for assessment of cardiac performance for the prediction of cardiovascular events: The multi-ethnic study of atherosclerosis. Hypertension, 61, 770-778.
16. Gosse, P. (2005). Left ventricular hypertrophy as a predictor of cardiovascular risk. Journal of Hypertension. Supplement, 23, S27-S33.
17. Anwar, A. M. (2012). Global and segmental myocardial deformation by 2D speckle tracking compared to visual assessment. World Journal of Cardiology, 4, 341-346.
18. Ng, W. Y., Lui, K. F., & Thai, A. C. (2000). Evaluation of a rapid screening test for microalbuminuria with a spot measurement of urine albumin-creatinine ratio. Annals of the Academy of Medicine, Singapore, 29, 62-65.
19. Thompson, E. W. (1994). Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: Effects of immediate and delayed insulin replacement. Proceedings of the Society for Experimental Biology and Medicine, 205, 294-305.
20. Naito, J., Koretsune, Y., Sakamoto, N., Shutta, R., Yoshida, J., Yasuoka, Y., et al. (2001). Transmural heterogeneity of myocardial integrated backscatter in diabetic patients without overt cardiac disease. Diabetes Research and Clinical Practice, 52, 11-20.
21. Raimondi, L., De Paoli, P., Mannucci, E., Lonardo, G., Sartiani, L., Banchelli, G., et al. (2004). Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats. Diabetes, 53, 1927-1933.
22. Rodrigues, B., Cam, M. C., & McNeill, J. H. (1998). Metabolic disturbances in diabetic cardiomyopathy. Molecular and Cellular Biochemistry, 180, 53-57.
23. Garvey, W. T., Hardin, D., Juhaszova, M., & Dominguez, J. H. (1993). Effects of diabetes on myocardial glucose transport system in rats: Implications for diabetic cardiomyopathy. American Journal of Physiology, 264, H837-H844.
24. Malone, J. I., Schocken, D. D., Morrison, A. D., & Gilbert-Barness, E. (1999). Diabetic cardiomyopathy and carnitine deficiency. Journal of Diabetes and Its Complications, 13, 86-90.
25. Malhotra, A., & Sanghi, V. (1997). Regulation of contractile proteins in diabetic heart. Cardiovascular Research, 34, 34-40.
26. Ng, A. C., Delgado, V., Bertini, M., van der Meer, R. W., Rijzewijk, L. J., Hooi Ewe, S., et al. (2010). Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation, 122, 2538-2544.
27. Sacre, J. W., Franjic, B., Jellis, C. L., Jenkins, C., Coombes, J. S., & Marwick, T. H. (2010). Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovascular Imaging, 3, 1207-1215.
28. Ganguly, P. K., Pierce, G. N., Dhalla, K. S., & Dhalla, N. S. (1983). Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. American Journal of Physiology, 244, E528-E535.
29. Giacomelli, F., & Wiener, J. (1979). Primary myocardial disease in the diabetic mouse. An ultrastructural study. Laboratory Investigation, 40, 460-473.
30. Regan, T. J., Wu, C. F., Yeh, C. K., Oldewurtel, H. A., & Haider, B. (1981). Myocardial composition and function in diabetes. The effects of chronic insulin use. Circulation Research, 49, 1268-1277.
31. Jellis, C., Wright, J., Kennedy, D., Sacre, J., Jenkins, C., Haluska, B., et al. (2011). Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circulation: Cardiovascular Imaging, 6, 693-702.
32. Yoon, Y. S., Uchida, S., Masuo, O., Cejna, M., Park, J. S., Gwon, H. C., et al. (2005). Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: Restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation, 111, 2073-2085.
33. Andersson, C., Gislason, G. H., Weeke, P., Hoffmann, S., Hansen, P. R., Torp-Pedersen, C., et al. (2010). Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovascular Diabetology, 18, 3.
34. Laakso, M. (2011). Heart in diabetes: A microvascular disease. Diabetes Care, 34, S145-S149.
35. Kawaguchi, M., Techigawara, M., Ishihata, T., Asakura, T., Saito, F., Maehara, K., et al. (1997). A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart and Vessels, 12, 267-274.
36. De Lorenzo, A., Lima, R. S., Siqueira-Filho, A. G., & Pantoja, M. R. (2002). Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. American Journal of Cardiology, 90, 827-832.
37. Huynh, K., Kiriazis, H., Du, X. J., Love, J. E., Jandeleit-Dahm, K. A., Forbes, J. M., et al. (2012). Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia, 55, 1544-1553.
38. Khong, F. L., Zhang, Y., Edgley, A. J., Qi, W., Connelly, K. A., Woodman, O. L., et al. (2011). 30, 40-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats. PLoS ONE, 6, e22777.
39. Nakai, H., Takeuchi, M., Nishikage, T., Lang, R. M., & Otsuji, Y. (2009). Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: Correlation with diabetic duration. European Journal of Echocardiography, 10, 926-932.
40. Pogatsa, G., Bihari-Varga, M., & Szinay, G. (1979). Effect of diabetes therapy on the myocardium in experimental diabetes. Acta Diabetologica Latina, 16, 129-138.
41. Litwin, S. E., Raya, T. E., Anderson, P. G., Daugherty, S., & Goldman, S. (1990). Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. Journal of Clinical Investigation, 86, 481-488.
42. Sanderson, J. E., & Fraser, A. G. (2006). Systolic dysfunction in heart failure with a normal ejection fraction: Echo-Doppler measurements. Progress in Cardiovascular Diseases, 49, 196-206.
43. Andersen, N. H., Poulsen, S. H., Eiskjaer, H., Poulsen, P. L., & Mogensen, C. E. (2003). Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: A Doppler tissue tracking and strain rate echocardiography study. Clinical Science (London), 105, 59-66.
44. Ha, J. W., Lee, H. C., Kang, E. S., Ahn, C. M., Kim, J. M., Ahn, J. A., et al. (2007). Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: Implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart, 93, 1571-1576.
45. Liu, J. E., Robbins, D. C., Palmieri, V., Bella, J. N., Roman, M. J., Fabsitz, R., et al. (2003). Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study. Journal of the American College of Cardiology, 41, 2022-2028.
46. Shim, C. Y., Park, S., Choi, E. Y., Kang, S. M., Cha, B. S., Ha, J. W., et al. (2008). Is albuminuria an indicator of myocardial dysfunction in diabetic patients without overt heart disease? A study with Doppler strain and strain rate imaging. Metabolism, 57, 448-452.